MA
Michael A Metzger sold $130K of SNDX stock
Michael A Metzger, Chief Executive Officer of Syndax Pharmaceuticals Inc (SNDX), sold 6,847 shares of SNDX stock worth $130K, per an SEC Form 4 filed Jun 2, 2026.
It was an open-market sale.
The trade happened on Jun 1, 2026, 1 day before it was made public.
SNDX has moved -49.3% since the trade date, from $18.85 to $9.55 (Nov 9, 2026 close).
- Traded
- Jun 1, 2026
- Disclosed
- Jun 2, 2026
- Filing delay
- 1 day
- Price since
- -49.3%
- Role
- Chief Executive Officer
- Source
- SEC Form 4